Literature DB >> 15818627

Corroboration of a familial chordoma locus on chromosome 7q and evidence of genetic heterogeneity using single nucleotide polymorphisms (SNPs).

Xiaohong ' Rose ' Yang1, Michael Beerman, Andrew W Bergen, Dilys M Parry, Eamonn Sheridan, Norbert J Liebsch, Michael J Kelley, Stephen Chanock, Alisa M Goldstein.   

Abstract

Chordoma, a rare bone tumor originating from notochordal remnants, has a genetic predisposition in some families. Previously, we performed linkage analysis using microsatellite (STR) markers on 3 unrelated chordoma kindreds (16 patients with chordoma) and reported significant evidence for linkage to chromosome 7q33 (Z(max) = 4.78) with a minimal disease gene region of 11 cM. In our present study, we performed linkage analysis in these 3 families using chromosome 7 single nucleotide polymorphisms (SNPs). Parametric and nonparametric multipoint analyses showed significant linkage to 7q markers with p < 0.001 and Z(max) = 2.77, respectively. The minimal disease gene region was not reduced by combined SNP and STR haplotype analysis compared to the previous STR haplotype analysis alone. We genotyped members of a fourth chordoma family with SNP and STR markers for chromosome 7q and for 1p36, the location of a previously reported chordoma locus. Affected members of this family did not share a common haplotype on 7q, and the family did not show evidence of linkage to 1p36. Thus, we corroborated a chordoma locus on chromosome 7q in the 3 original families and demonstrated evidence for genetic heterogeneity in the fourth family. Our study also provided insights into some limitations and analytical complexities associated with using a dense SNP marker set in linkage analysis of complex pedigrees.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818627     DOI: 10.1002/ijc.21006

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.

Authors:  Dilys M Parry; Mary L McMaster; Norbert J Liebsch; Nicholas J Patronas; Martha M Quezado; Deborah Zametkin; Xiaohong R Yang; Alisa M Goldstein
Journal:  J Neurosurg       Date:  2020-06-19       Impact factor: 5.115

2.  The advantages of dense marker sets for linkage analysis with very large families.

Authors:  Russell Thomson; Stephen Quinn; James McKay; Jeremy Silver; Melanie Bahlo; Liesel FitzGerald; Simon Foote; Jo Dickinson; Jim Stankovich
Journal:  Hum Genet       Date:  2007-01-25       Impact factor: 4.132

3.  Multipoint linkage analysis with many multiallelic or dense diallelic markers: Markov chain-Monte Carlo provides practical approaches for genome scans on general pedigrees.

Authors:  Ellen M Wijsman; Joseph H Rothstein; Elizabeth A Thompson
Journal:  Am J Hum Genet       Date:  2006-09-20       Impact factor: 11.025

4.  The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.

Authors:  Craig Horbinski; Gerard J Oakley; Kathleen Cieply; Geeta S Mantha; Marina N Nikiforova; Sanja Dacic; Raja R Seethala
Journal:  Arch Pathol Lab Med       Date:  2010-08       Impact factor: 5.534

5.  Familial chordoma: A case report and review of the literature.

Authors:  K E Wang; Zhen Wu; Kaibing Tian; Liang Wang; Shuyu Hao; Liwei Zhang; Junting Zhang
Journal:  Oncol Lett       Date:  2015-09-09       Impact factor: 2.967

6.  Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.

Authors:  Xiaoyun Wen; Robert Cimera; Ruth Aryeequaye; Mohanty Abhinta; Edward Athanasian; John Healey; Nicola Fabbri; Patrick Boland; Yanming Zhang; Meera Hameed
Journal:  Genes Chromosomes Cancer       Date:  2021-08-26       Impact factor: 5.006

7.  Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas.

Authors:  Sangyeul Han; Carolyn Polizzano; Gunnlaugur P Nielsen; Francis J Hornicek; Andrew E Rosenberg; Vijaya Ramesh
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

8.  T (brachyury) gene duplication confers major susceptibility to familial chordoma.

Authors:  Xiaohong R Yang; David Ng; David A Alcorta; Norbert J Liebsch; Eamonn Sheridan; Sufeng Li; Alisa M Goldstein; Dilys M Parry; Michael J Kelley
Journal:  Nat Genet       Date:  2009-10-04       Impact factor: 38.330

9.  Genomic aberrations frequently alter chromatin regulatory genes in chordoma.

Authors:  Lu Wang; Ahmet Zehir; Khedoudja Nafa; Nengyi Zhou; Michael F Berger; Jacklyn Casanova; Justyna Sadowska; Chao Lu; C David Allis; Mrinal Gounder; Chandhanarat Chandhanayingyong; Marc Ladanyi; Patrick J Boland; Meera Hameed
Journal:  Genes Chromosomes Cancer       Date:  2016-05-09       Impact factor: 5.006

Review 10.  From notochord formation to hereditary chordoma: the many roles of Brachyury.

Authors:  Yutaka Nibu; Diana S José-Edwards; Anna Di Gregorio
Journal:  Biomed Res Int       Date:  2013-03-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.